Cortical excitability study in person with sleep bruxism during pre- and post- treatment with botulinum toxin A injectio
- Conditions
- sleep bruxismBruxism, Cortical excitability, Cortical silent period, Masseter inhibitory reflexes, Masseter
- Registration Number
- TCTR20230224002
- Lead Sponsor
- Ratchadapiseksompotch Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
subject identified as having bruxism in accordance with the international consensus definition of bruxism
Exclusion Criteria
1. previous history of seizure
2. has cardiac pace maker
3. has metal implantation
4. pregnancy
- treatment with botulinum toxin A in past three months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cortical excitability Pre-dose and at 4 weeks post-dose Cortical silent period
- Secondary Outcome Measures
Name Time Method Masseter inhibitory reflexes Pre-dose and at 4 weeks post-dose millisecond